4-oxatetradecanoic acid has been researched along with 2019 Novel Coronavirus Disease in 1 studies
4-oxatetradecanoic acid: fungicidal for Cryptococcus neoformans & inhibits replication of HIV I; structure given in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Sayed, NS | 1 |
| Jureka, AS | 1 |
| Edwards, MR | 1 |
| Lohan, S | 1 |
| Williams, CG | 1 |
| Keiser, PT | 1 |
| Davey, RA | 1 |
| Totonchy, J | 1 |
| Tiwari, RK | 1 |
| Basler, CF | 1 |
| Parang, K | 1 |
1 other study available for 4-oxatetradecanoic acid and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Synthesis and antiviral activity of fatty acyl conjugates of remdesivir against severe acute respiratory syndrome coronavirus 2 and Ebola virus.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19; Ebolavirus; Fatty Acids; Humans; SARS- | 2021 |